Investing Profile

Larry Lasky

InvestorVC

Partner at The Column Group

Your Intro Paths to Larry Lasky

Signal uses Gmail to reveal intro paths. Email content is never read.

Find Larry Lasky on

Current Investing Position

Investment Range

$100K - $5.0M

Sweet Spot

$1.5M

Investments On Record

Current Fund Size

$600M

Larry Lasky is on these Sector & Stage Rankings

Larry Lasky's Investments On Record (6)

Company	StageDateRound Size	Total Raised
Eikon Therapeutics	Series DFeb 2025$350M Series BJan 2022$520M Series AMay 2021$150M	$1B
Co-investors: Josh Wolfe (Lux Capital), Adam Goulburn (Dimension Capital), Leon Chen (The Column Group), Dror Berman (Innovation Endeavors), Eric Schmidt (Innovation Endeavors)
Accent Therapeutics	Series CJan 2024$75M Series BApr 2020$63M Series AMay 2018$40M	$180M
Co-investors: Jason Rhodes (Atlas Venture), Naveen Krishnan (Leaps by Bayer)
Revolution Medicines	Series CJul 2019$100M Series BApr 2018$56M Series ADec 2016$25M	$180M
Co-investors: Thilo Schroeder (Nextech Invest)
Cleave Therapeutics	Series ANov 2011$42M	$100M
Co-investors: Robert Garland (New Enterprise Associates (NEA)), Carol Gallagher (New Enterprise Associates (NEA)), Kush Parmar (5am Ventures), Andrew Schwab (5am Ventures), Peter Thompson (OrbiMed), Marc Singer (Osage University Partners), Alfred Scheidegger (Nextech Invest)
Calithera Biosciences	Series UnknownNov 2011$4M Series AJul 2010$40M	$81M
Co-investors: Ralph (Chris) Christoffersen (Morgenthaler Ventures), Jean George (Advanced Technology Ventures), Christoph Westphal (Longwood Fund)
OncoMed Pharmaceuticals	Series BNov 2008$150M Series ASep 2005$14M	$170M
Co-investors: Jonathan Root (U.S. Venture Partners (USVP))